Finzati - Logo
IMCC logo

IM Cannabis Corp.

IMCCDrug Manufacturers - Specialty & Generic
Strong market move
IMCC-10.00%
vs. previous close $2.20
$1.98
-0.22 (-10.00%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$323,664
Growth
-11.5%
Cash Flow
1/5
Trend
Volatile
Evidence
Positive free cash flow · 1.11Weak liquidity · 0.67Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 19, 2026, 12:24 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$1.98
Change-10.00%
Market Cap$323.66K
52W Range0.09 - 2.61
Beta2.06
Gross Margin17.70%
Oper. Margin-21.17%
Profit Margin-20.68%
Debt/Eq-18.96
Current Ratio0.67
Quick Ratio0.54
Revenue 5Y-11.46%

Investment DNA

How strong this company looks for long-term investors

49
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
62/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score
Positive free cash flow · 1.11Weak liquidity · 0.67Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 5/20/2020
Industry: Drug Manufacturers - Specialty & Generic
P/B i: -9.42
Debt / Equity i: -18.96
Operating Margin: -21.17%
Net Margin: -20.68%
ROE i: -
ROIC: -

Financial Health

Score4 / 20
Debt / Equity: -18.96
Current Ratio: 0.67
Quick Ratio: 0.54
Status: HighRisk

Warnings

  • Weak Liquidity
  • Weak quick ratio
🧾

No insider activity

No recent insider transactions available.